ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ABOS Acumen Pharmaceuticals Inc

2.62
0.13 (5.22%)
取引時間後
最終更新日: 05:31:59
15分遅延
名称 銘柄コード 市場 種別
Acumen Pharmaceuticals Inc ABOS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.13 5.22% 2.62 05:31:59
始値 安値 高値 終値 前日終値
2.49 2.46 2.63 2.62 2.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0605:36EDGAR2Form 8-K - Current report
2024/5/1505:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1420:35EDGAR2Form 8-K - Current report
2024/5/1420:00GLOBEAcumen Pharmaceuticals Reports First Quarter 2024 Financial..
2024/5/1405:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
2024/5/0906:47GLOBEAcumen Pharmaceuticals to Participate in the 2024 Bank of..
2024/5/0821:00GLOBEAcumen Pharmaceuticals Announces First Patient Dosed in..
2024/5/0805:00GLOBEAcumen Pharmaceuticals to Report First Quarter Results on..
2024/4/1621:00GLOBEAcumen Pharmaceuticals Presents First Comprehensive Clinical..
2024/4/0421:00GLOBEAcumen Pharmaceuticals Collaborates with Lonza to Advance..
2024/3/2620:00GLOBEAcumen Pharmaceuticals Reports Financial Results for the..
2024/3/2121:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights, Including..
2024/3/2005:00GLOBEAcumen Pharmaceuticals to Report Fourth Quarter and Year-End..
2024/3/1305:00GLOBEAcumen Pharmaceuticals to Participate in the Stifel 2024 CNS..
2024/3/0822:50GLOBEAcumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid..
2024/2/2122:00GLOBEAcumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid..
2024/2/1422:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0207:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0207:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/0121:16EDGAR2Form 8-K - Current report
2024/2/0121:00GLOBEAcumen Pharmaceuticals Appoints Dr. James Doherty as..
2024/1/2009:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2009:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2009:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2009:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2009:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2006:36EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2006:35EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1906:29EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1906:28EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1906:27EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1222:42EDGAR2Form 8-K - Current report
2024/1/0822:33EDGAR2Form 8-K - Current report
2024/1/0506:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:15GLOBEAcumen Pharmaceuticals to Present at the 42nd Annual J.P...
2023/12/0421:45EDGAR2Form 8-K - Current report
2023/11/1407:10EDGAR2Form 8-K - Current report
2023/11/1406:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1321:20EDGAR2Form 8-K - Current report
2023/11/1321:00GLOBEAcumen Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0806:01GLOBEAcumen Pharmaceuticals to Participate in the Stifel..
2023/11/0706:01GLOBEAcumen Pharmaceuticals to Report Third Quarter Financial..
2023/11/0621:30GLOBEAcumen Pharmaceuticals, Inc. and Halozyme Enter Global..
2023/11/0305:00GLOBEAcumen Pharmaceuticals to Participate in the UBS Biopharma..
2023/10/2722:25GLOBEAcumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates..
2023/10/0421:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights from..

最近閲覧した銘柄

Delayed Upgrade Clock